This study was centred around continuing medical education for both secondary and primary care doctors and asked what role the pharmaceutical industry should play. It aimed to answer the following question: Are doctors getting what they need?
Over 1,500 European physicians from our panel participated in this study from wide range of specialties including general practice, cardiology, neurology, rheumatology, endocrinology and infectious diseases.
You can access the results of the study below.
How to make extra money during the holiday season as a physician? Participating in paid healthcare market research studies with M3 offers a flexible and lucrative opportunity, especially for physicians.
Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.
Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.
2 comments
this blog clearly identify the needs of the doctors , the parma is a main support to the doctors i refereed the following link for my suggestion
http://www.fernedu.com/study-in-phillipines/
Thank you very much for your comment. We are glad to hear that our content is interesting and relevant for our doctors and readers! Thank you. The M3 Global Research team.